It's that time once again. Gilead Sciences (NASDAQ:GILD) is scheduled to announce its 2020 first-quarter results after the market closes on Thursday, April 30, 2020.
The last time the big biotech reported its quarterly results, it topped Wall Street revenue expectations but fell well below earnings estimates. Gilead also provided what could fairly be described as lackluster guidance for full-year 2020.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,